Suchergebnisse - "Borghi, Vanni"

PubPharm (155)

1

Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia

enthalten in: Frontiers in medicine | 2024

von Cozzi-Lepri, A. | Borghi, V. | Rotundo, S. | +27

2

Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir : Results from clinical practice

enthalten in: International journal of antimicrobial agents | 2024

von Ciccullo, A. | Baldin, G. | Borghi, V. | +9

3

Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors : A retrospective cohort study

enthalten in: Journal of medical virology | 2023

von Lagi, F. | Giacomelli, A. | Borghi, V. | +12

4

Real-life experience with remdesivir for treatment of COVID-19 among older adults : a multicentre retrospective study

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Margalit, I. | Tiseo, G. | Ripa, M. | +12

5

Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients

enthalten in: Viruses | 2023

von Fabbiani, M. | Masini, M. | Rossetti, B. | +13

6

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital : derivation and validation of the FLAMINCOV score

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Tiseo, G. | Margalit, I. | Ripa, M. | +15

7

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype

enthalten in: Viruses | 2023

von Salvo, P. | Farinacci, D. | Ciccullo, A. | +11

8

Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures

enthalten in: Journal of global antimicrobial resistance | 2023

von Gagliardini, R. | Lorenzini, P. | Cozzi-Lepri, A. | +9

9

Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy

enthalten in: Sexually transmitted infections | 2023

von Bozzi, G. | Fabeni, L. | Abbate, I. | +68

10

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study

enthalten in: Viruses | 2023

von Mussini, C. | Cozzi-Lepri, A. | Meschiari, M. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]